Literature DB >> 19557727

Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.

Catherine R Planey1, E Brian Welch, Lei Xu, A Bapsi Chakravarthy, J Christopher Gatenby, Darla Freehardt, Ingrid Mayer, Ingrid Meszeoly, Mark Kelley, Julie Means-Powell, John C Gore, Thomas E Yankeelov.   

Abstract

PURPOSE: To assess the temporal sampling requirements needed for quantitative analysis of dynamic contrast-enhanced MRI (DCE-MRI) data with a reference region (RR) model in human breast cancer.
MATERIALS AND METHODS: Simulations were used to study errors in pharmacokinetic parameters (K(trans) and v(e)) estimated by the RR model using six DCE-MRI acquisitions over a range of pharmacokinetic parameter values, arterial input functions, and temporal samplings. DCE-MRI data were acquired on 12 breast cancer patients and parameters were estimated using the native resolution data (16.4 seconds) and compared to downsampled 32.8-second and 65.6-second data.
RESULTS: Simulations show that, in the majority of parameter combinations, the RR model results in an error less than 20% in the extracted parameters with temporal sampling as poor as 35.6 seconds. The experimental results show a high correlation between K(trans) and v(e) estimates from data acquired at 16.4-second temporal resolution compared to the downsampled 32.8-second data: the slope of the regression line was 1.025 (95% confidence interval [CI]: 1.021, 1.029), Pearson's correlation r = 0.943 (95% CI: 0.940, 0.945) for K(trans), and 1.023 (95% CI: 1.021. 1.025), r = 0.979 (95% CI: 0.978, 0.980) for v(e). For the 64-second temporal resolution data the results were: 0.890 (95% CI: 0.894, 0.905), r = 0.8645, (95% CI: 0.858, 0.871) for K(trans), and 1.041 (95% CI: 1.039, 1.043), r = 0.970 (95% CI: 0.968, 0.971) for v(e).
CONCLUSION: RR analysis allows for a significant reduction in temporal sampling requirements and this lends itself to analyze DCE-MRI data acquired in practical situations. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557727      PMCID: PMC2782711          DOI: 10.1002/jmri.21812

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  43 in total

1.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Martin Lepage; Rui Li; Laura Debusk; P Charles Lin; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2005-05       Impact factor: 2.546

2.  Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data.

Authors:  Thomas E Yankeelov; Greg O Cron; Christina L Addison; Julia C Wallace; Ruth C Wilkins; Bruce A Pappas; Giles E Santyr; John C Gore
Journal:  Magn Reson Med       Date:  2007-02       Impact factor: 4.668

Review 3.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

4.  Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.

Authors:  Constance D Lehman; Jeffrey D Blume; Paul Weatherall; David Thickman; Nola Hylton; Ellen Warner; Etta Pisano; Stuart J Schnitt; Constantine Gatsonis; Mitchell Schnall; Gia A DeAngelis; Paul Stomper; Eric L Rosen; Michael O'Loughlin; Steven Harms; David A Bluemke
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

5.  Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: comparison with a fixed vascular input function.

Authors:  S Walker-Samuel; C C Parker; M O Leach; D J Collins
Journal:  Phys Med Biol       Date:  2006-12-06       Impact factor: 3.609

6.  Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.

Authors:  Chen-Pin Chou; Ming-Ting Wu; Hong-Tai Chang; Yu-Shin Lo; Huay-Ben Pan; Hadassa Degani; Edna Furman-Haran
Journal:  Acad Radiol       Date:  2007-05       Impact factor: 3.173

7.  Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

Authors:  Susan M Galbraith; Martin A Lodge; N Jane Taylor; Gordon J S Rustin; Søren Bentzen; J James Stirling; Anwar R Padhani
Journal:  NMR Biomed       Date:  2002-04       Impact factor: 4.044

8.  Temporal sampling requirements for the tracer kinetics modeling of breast disease.

Authors:  E Henderson; B K Rutt; T Y Lee
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

9.  Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.

Authors:  Anwar R Padhani; Carmel Hayes; Laura Assersohn; Trevor Powles; Andreas Makris; John Suckling; Martin O Leach; Janet E Husband
Journal:  Radiology       Date:  2006-03-16       Impact factor: 11.105

10.  Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.

Authors:  P S Tofts; B Berkowitz; M D Schnall
Journal:  Magn Reson Med       Date:  1995-04       Impact factor: 4.668

View more
  14 in total

1.  Simulation study of the effect of golden-angle KWIC with generalized kinetic model analysis on diagnostic accuracy for lesion discrimination.

Authors:  Melanie Freed; Sungheon G Kim
Journal:  Magn Reson Imaging       Date:  2014-09-28       Impact factor: 2.546

2.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Authors:  Nola M Hylton; Jeffrey D Blume; Wanda K Bernreuter; Etta D Pisano; Mark A Rosen; Elizabeth A Morris; Paul T Weatherall; Constance D Lehman; Gillian M Newstead; Sandra Polin; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

3.  Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.

Authors:  Anna G Sorace; Savannah C Partridge; Xia Li; Jack Virostko; Stephanie L Barnes; Daniel S Hippe; Wei Huang; Thomas E Yankeelov
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

Review 4.  The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer.

Authors:  Thomas E Yankeelov; Lori R Arlinghaus; Xia Li; John C Gore
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

5.  A linear algorithm of the reference region model for DCE-MRI is robust and relaxes requirements for temporal resolution.

Authors:  Julio Cárdenas-Rodríguez; Christine M Howison; Mark D Pagel
Journal:  Magn Reson Imaging       Date:  2012-12-08       Impact factor: 2.546

6.  Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.

Authors:  Lori R Arlinghaus; Xia Li; Mia Levy; David Smith; E Brian Welch; John C Gore; Thomas E Yankeelov
Journal:  J Oncol       Date:  2010-09-29       Impact factor: 4.375

7.  Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis.

Authors:  Federico D Pineda; Milica Medved; Shiyang Wang; Xiaobing Fan; David V Schacht; Charlene Sennett; Aytekin Oto; Gillian M Newstead; Hiroyuki Abe; Gregory S Karczmar
Journal:  Acad Radiol       Date:  2016-06-06       Impact factor: 3.173

8.  Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors.

Authors:  Chengyue Wu; Federico Pineda; David A Hormuth; Gregory S Karczmar; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2018-10-28       Impact factor: 4.668

9.  Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294.

Authors:  Kiaran P McGee; Ken-Pin Hwang; Daniel C Sullivan; John Kurhanewicz; Yanle Hu; Jihong Wang; Wen Li; Josef Debbins; Eric Paulson; Jeffrey R Olsen; Chia-Ho Hua; Lizette Warner; Daniel Ma; Eduardo Moros; Neelam Tyagi; Caroline Chung
Journal:  Med Phys       Date:  2021-05-20       Impact factor: 4.071

10.  Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.

Authors:  Cédric de Bazelaire; Raphael Calmon; Isabelle Thomassin; Clément Brunon; Anne-Sophie Hamy; Laure Fournier; Daniel Balvay; Marc Espié; Nathalie Siauve; Olivier Clément; Eric de Kerviler; Charles-André Cuénod
Journal:  BMC Cancer       Date:  2011-08-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.